IL6 and COVID-19: Low blood levels of plasmin and its precursor plasminogen correlate with a high risk for mortality and are associated with IL-6 upregulation in COVID-19 patients [27,28,44], reflecting its potential contribution to profibrogenic uPA accumulation and low-level fibrinolysis.